Bio-Rad Laboratories (NYSE:BIO.B) Sets New 1-Year Low – Time to Sell?

Bio-Rad Laboratories, Inc. (NYSE:BIO.B)’s share price reached a new 52-week low during trading on Wednesday . The stock traded as low as $225.29 and last traded at $225.29, with a volume of 120 shares. The stock had previously closed at $241.99.

Bio-Rad Laboratories Stock Performance

The firm has a market cap of $6.31 billion, a price-to-earnings ratio of -3.46 and a beta of 0.75. The stock’s fifty day moving average is $281.66 and its two-hundred day moving average is $317.25. The company has a debt-to-equity ratio of 0.18, a quick ratio of 4.85 and a current ratio of 6.48.

Bio-Rad Laboratories (NYSE:BIO.B) last announced its quarterly earnings results on Thursday, February 13th. The company reported $2.90 EPS for the quarter. Bio-Rad Laboratories had a negative net margin of 71.86% and a positive return on equity of 3.90%.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.